SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,330 | -53.9% | 30,560 | 0.0% | 0.00% | – |
| Q2 2023 | $39,728 | -68.0% | 30,560 | -56.7% | 0.00% | -100.0% |
| Q1 2023 | $124,186 | -38.7% | 70,560 | +9.3% | 0.00% | -50.0% |
| Q4 2022 | $202,718 | +1.9% | 64,560 | +59.2% | 0.00% | 0.0% |
| Q3 2022 | $199,000 | +134.1% | 40,560 | +97.3% | 0.00% | +100.0% |
| Q2 2022 | $85,000 | -28.6% | 20,560 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $119,000 | -22.7% | 20,560 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $154,000 | -16.8% | 20,560 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $185,000 | -24.8% | 20,560 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $246,000 | -4.7% | 20,560 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $258,000 | -59.8% | 20,560 | -50.0% | 0.00% | 0.0% |
| Q4 2020 | $642,000 | – | 41,120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |